• Cathepsin B Inhibitor CA-074: Technical Guide for Disease Mo

  2026-06-18

  Cathepsin B inhibitor CA-074 provides researchers with a highly selective, nanomolar-potency tool for dissecting cathepsin B’s roles in cancer metastasis, neurotoxicity, and immune modulation. This compound is best suited for biochemical and cell-based assays where off-target inhibition of related cathepsins must be minimized. Use is not advised for applications requiring prolonged solution stability or unclear cathepsin isoform selectivity.

• FLOT1-FOSL2-EphA2 Axis Drives Microglial Polarization in AD

  2026-06-18

  This study uncovers how the interaction of FLOT1 with FOSL2 promotes EphA2 transcription, triggering pro-inflammatory microglial polarization via the p38/MAPK pathway in Alzheimer's disease. The findings highlight a novel mechanistic axis governing neuroinflammation and cognitive decline, providing actionable targets for intervention.

• VE-821: Elevating ATR Inhibition for DNA Damage & Epigenetic

  2026-06-17

  This thought-leadership article explores how VE-821, a next-generation ATR kinase inhibitor, empowers translational researchers to dissect DNA damage response (DDR) mechanisms and advance combination therapy strategies. Integrating recent mechanistic insights—including the interplay between host epigenetics and viral replication—this piece provides actionable guidance on protocol optimization, competitive positioning, and the translational potential of ATR inhibition in oncology and virology.

• Proteomic Dissection of Platycodin D-Induced Apoptosis in NS

  2026-06-17

  This study applies advanced multidimensional proteomics to elucidate the pro-apoptotic mechanisms of Platycodin D in non-small cell lung cancer (NSCLC). By identifying RFC4 as a direct target and mapping its effect on the Notch signaling axis, the research provides a mechanistic foundation for developing new apoptosis-inducing strategies in NSCLC.

• Ciprofloxacin in Research: Advanced Fluoroquinolone Workflow

  2026-06-16

  Ciprofloxacin, a benchmark fluoroquinolone antibiotic, offers unique advantages in experimental modeling of bacterial resistance and targeted therapeutic delivery. Discover optimized protocols, troubleshooting strategies, and the latest nanotheranostic innovations to elevate your bench research.

• Cy5 NHS ester(Et): Practical Guidance for Fluorescent Labeli

  2026-06-16

  Cy5 NHS ester(Et) provides a reliable solution for covalent, water-soluble fluorescent labeling of primary amines in biomolecules, supporting workflows such as immunofluorescence, flow cytometry, and fluorescence microscopy. This reagent should not be used with ethanol-based protocols or for the long-term storage of prepared solutions, as these conditions compromise labeling performance and reagent integrity.

• Amyloid Beta-peptide (25-35): Applied Neurotoxicity Modeling

  2026-06-15

  Amyloid Beta-peptide (25-35) (Aβ25-35) is the gold-standard model for inducing neurotoxicity and dissecting microglial polarization in Alzheimer's disease research. This guide delivers stepwise protocols, troubleshooting, and cutting-edge insights for maximizing reproducibility and mechanistic clarity with APExBIO's trusted reagent.

• Scenario-Driven Laboratory Solutions with Cell Counting Kit-

  2026-06-15

  This article delivers evidence-based, scenario-driven guidance for biomedical researchers using Cell Counting Kit-8 (CCK-8), SKU K1018. Drawing on real-world laboratory challenges, it demonstrates how the kit provides reproducible, sensitive cell viability and cytotoxicity data while streamlining workflows.

• 2-Hydroxypropyl-β-cyclodextrin: Solubility Protocols & QC Gu

  2026-06-14

  2-Hydroxypropyl-β-cyclodextrin addresses the persistent challenge of solubilizing poorly water-soluble, hydrophobic compounds—especially those containing aromatic or phenyl groups—in pharmaceutical and biochemical research. Its use should be limited to roles as a drug formulation excipient or for improving pharmaceutical solubility, as broader or therapeutic applications are not supported by current documentation.

• Nintedanib (BIBF 1120): Precision Targeting in ATRX-Deficien

  2026-06-13

  Explore the multifaceted role of Nintedanib (BIBF 1120) as a triple angiokinase inhibitor in ATRX-deficient cancer research. This article offers a unique, practical perspective on mechanistic selectivity, protocol optimization, and translational opportunities for antiangiogenic therapy.

• CCCP in Mitochondrial Dysfunction Assays: Protocols & Innova

  2026-06-12

  CCCP (carbonyl cyanide m-chlorophenyl hydrazine) is the gold-standard tool for disrupting mitochondrial proton gradients, enabling precise modeling of bioenergetic failure in live-cell systems. This article guides researchers through workflow setup, advanced troubleshooting, and best-practices for integrating CCCP into deep learning–enabled mitochondrial assays.

• DiR (DiIC 18 (7)) for Robust Membrane and EV Tracking Workfl

  2026-06-12

  DiR (DiIC 18 (7)) delivers unmatched stability and sensitivity for live and fixed cell membrane imaging, empowering advanced extracellular vesicle (EV) tracking even in challenging in vivo environments. Its near-infrared emission and minimal cytotoxicity position it as a cornerstone for long-term, high-resolution imaging and emerging therapeutic paradigms.

• Otilonium Bromide: Mechanistic Insights for Cholinergic Path

  2026-06-11

  Explore the advanced mechanism of Otilonium Bromide as an antimuscarinic agent in modulating cholinergic signaling pathways. This article uniquely dissects receptor-level actions, assay optimization, and protocol design for neuroscience and smooth muscle research—distinct from scenario-driven or translational applications.

• (S)-1-(3-fluoro-4-(trifluoromethoxy)phenyl)...Urea in Osteoc

  2026-06-11

  Explore how (S)-1-(3-fluoro-4-(trifluoromethoxy)phenyl)-3-(1-(2-methylbutanoyl)piperidin-4-yl)urea (BPN-19186) enables advanced study of sEH–Nrf2 signaling in bone metabolism. This article offers unique assay guidance and translational insight for signaling pathway modulation and enzyme inhibition research.

• Gentamycin Sulfate: Precision Tools for Resistance Research

  2026-06-10

  Gentamycin Sulfate, an aminoglycoside antibiotic, empowers researchers to dissect ribosome function and resistance mechanisms in Gram-negative bacteria. This guide details optimized workflows, comparative insights, and practical troubleshooting for robust, reproducible assays.

449 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page